Skip to main content
Back
SHPPF logo

Redcare Pharmacy N.V.

Data quality: 100%
Oversold
SHPPF
OTC Healthcare Medical - Pharmaceuticals
$45.18
$0.00 (0.00%)
Mkt Cap: 919.02M
Also listed as SAEYY OTC
Day Range
$45.18 $62.99
52-Week Range
$45.18 $148.22
Volume
400
50D / 200D Avg
$66.04 / $102.10
Prev Close
$45.18

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -24.4 0.4
P/B 2.0 2.9
ROE % -8.0 3.8
Net Margin % -1.3 3.9
Rev Growth 5Y % 29.0 10.0
D/E 0.9 0.2

Key Takeaways

Revenue grew 29.04% annually over 5 years — strong growth
Negative free cash flow of -56.28M
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.03%
Capital efficient — spends only 2.70% of revenue on capex

Growth

Revenue Growth (5Y)
29.04%
Revenue (1Y)24.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-7.99%
ROIC-2.04%
Net Margin-1.28%
Op. Margin-0.81%

Safety

Debt / Equity
0.91
Current Ratio1.55
Interest Coverage-1.17

Valuation

P/E Ratio
-24.39
P/B Ratio2.00
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 24.01% Revenue Growth (3Y) 27.84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 29.04% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.94B Net Income (TTM) -37.69M
ROE -7.99% ROA -3.02%
Gross Margin 20.19% Operating Margin -0.81%
Net Margin -1.28% Free Cash Flow (TTM) -56.28M
ROIC -2.04% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.91 Current Ratio 1.55
Interest Coverage -1.17 Dividend Yield 0.00%
Valuation
P/E Ratio -24.39 P/B Ratio 2.00
P/S Ratio 0.31 PEG Ratio 1.97
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 919.02M Enterprise Value 1.24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.94B 2.37B 1.80B 1.20B 1.06B
Net Income -37.69M -45.46M -12.04M -77.65M -74.19M
EPS (Diluted) -1.87 -2.26 -0.63 -4.32 -4.15
Gross Profit 593.48M 545.78M 440.38M 331.79M 266.53M
Operating Income -23.79M -38.99M -17.30M -69.17M -65.70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.25B 1.00B 1.02B 729.47M 783.08M
Total Liabilities 767.01M 493.32M 469.56M 374.84M 367.66M
Shareholders' Equity 459.03M 483.98M 522.19M 354.63M 415.41M
Total Debt 415.44M 247.38M 244.84M 255.19M 236.43M
Cash & Equivalents 92.37M 96.61M 83.78M 66.44M 247.08M
Current Assets 619.17M 500.02M 499.52M 343.92M 432.76M
Current Liabilities 399.85M 249.73M 223.72M 119.31M 124.09M

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#105 of 614
66
Custom Full Throttle
#96 of 146
35

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered Full Throttle
Mar 24, 2026